tm logo
IMMY
Live/Pending
REQUEST FOR EXTENSION OF TIME TO FILE OPPOSITION

on 10 Dec 2024

Last Applicant/ Owned by

2701 Corporate Centre Dr.

Norman

OK

73069

Serial Number

98195832 filed on 25th Sep 2023

Registration Number

N/A

Correspondent Address

Emily E Campbell

Emily E Campbell Dunlap Codding, P.C.

Oklahoma City, OK 73113

United States

Filing Basis

1. filed as use application

2. use application currently

Disclaimer

NO DATA

IMMY

Medical diagnostic apparatus, namely, diagnostic kits comprising diagnostic reagents and assays for testing for the presence of certain antigens, antibodies, and biomarkers

Classification Information


Class [005]
Pharmaceutical Products


Medical diagnostic apparatus, namely, diagnostic kits comprising diagnostic reagents and assays for testing for the presence of certain antigens, antibodies, and biomarkers


First Use Date in General

01st Jan 2012

First Use Date in Commerce

01st Jan 2012

Mark Details


Serial Number

No 98195832

Mark Type

No Service/Collective Mark

Attorney Docket Number

No 3609.008

44D Filed

No

44D Current

No

44E filed

No

44E Current

No

66A Filed

No

66A Current

No

Current Basis

No

No Basis

No

Design Code(s)

01.01.02 -

A single star with four points

26.01.01 -

Circles as carriers or as single line borders

26.01.12 -

Circles with bars, bands and lines

26.01.21 -

Circles that are totally or partially shaded

26.07.01 -

Plain diamonds with single or multiple line borders

Legal History


Show more

Status DateAction Taken
10th Dec 2024EXTENSION OF TIME TO OPPOSE RECEIVED
10th Dec 2024OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
10th Dec 2024PUBLISHED FOR OPPOSITION
04th Dec 2024NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
12th Nov 2024APPROVED FOR PUB - PRINCIPAL REGISTER
05th Nov 2024TEAS/EMAIL CORRESPONDENCE ENTERED
04th Nov 2024TEAS RESPONSE TO OFFICE ACTION RECEIVED
04th Nov 2024CORRESPONDENCE RECEIVED IN LAW OFFICE
31st Jul 2024APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED
31st Jul 2024APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED